Cephea Early Feasibility Study

What is the Purpose of this Study?

The purpose of this study is to evaluate an investigational device called the Cephea Mitral Valve System, which is designed for the treatment of a diseased, damaged, or malfunctioning mitral valve. Specifically, the study aims to determine the safety and effectiveness of the Cephea Mitral Valve system for the treatment of a leaking mitral valve. Researchers want to test this device because it is a less invasive procedure than open heart surgical replacement of the mitral valve.

The study focuses on patients who have been diagnosed with mitral valve regurgitation, a condition in which the heart’s mitral valve does not close tightly, causing blood to flow backward in the heart. Stopping or decreasing mitral regurgitation helps blood flow more efficiently through the heart and the rest of the body. The Cephea Mitral Valve System includes the valve and an instrument set that allow study doctors to implant the valve. The valve is placed within the natural mitral valve.


Eligibility

  • * Mitral valve disease resulting in mitral regurgitation (MR ≥ Grade III) and/or severe mitral valve stenosis (mitral valve area ≤ 1.5cm²) per American Society of Echocardiography criteria.
  • * LVEF ≥ 30%
  • * In the judgement of the Site Heart Team, transcatheter therapy is deemed more appropriate than open heart surgery.
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

Cephea Early Feasibility Study

Study Details
Disease Type/Condition

Other

Principal Investigator

Makkar, Rajendra

Age Group

Adult

Phase

I/II

IRB Number

STUDY00001703

ClinicalTrials.gov ID

NCT05061004

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Makkar, Rajendra

Age Group

Adult

Phase

I/II

IRB Number

ABT-CIP-10354

ClinicalTrials.gov ID

NCT05061004

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org